The global chronic disease management market was valued at $4,896.69 million in 2021 and is projected to reach $14,875.48 million by 2031, registering a CAGR of 11.8% from 2022 to 2031.
Chronic disease management is an integrated care approach to managing the illness, which includes screenings, check-ups, monitoring and coordinating treatment, and patient education. It can improve the quality of life, while reducing healthcare costs. Chronic disease management programs are designed to improve the health of individuals with chronic conditions and reduce associated costs from avoidable complications by identifying and treating chronic conditions more quickly and more effectively; thus slowing the progression of those diseases.
The key factors that drive the growth of the market are an increase in awareness regarding the healthcare management service and a rise in the prevalence of chronic diseases such as cancer, heart disease, diabetes, high blood pressure, and others. According to a report published by the World Health Organization, in 2021, non-communicable diseases (NCDs) killed around 41 million people each year, which was 71% of all deaths globally. Moreover, improved services by the service provider have increased the demand for chronic disease management services in the market. The growth in the medical tourism sector and the rise in healthcare IT solutions drive the growth of the chronic disease management market. However, a lack of skilled professionals and high cost of treatment, and high investment in the management system/tools hinder the growth of the market.
The chronic disease management market is segmented on the basis of type, disease type, end user, and region. By type, the market is bifurcated into solutions and services. The solution segment is further classified on the basis of an on-premise solution and a cloud-based solution. On the basis of service, the segment is segmented into educational service, implementation service, and consulting service. On the basis of disease type, the segment is divided into cardiovascular disease, diabetes, cancer, asthma, a chronic obstructive pulmonary disorder, and others. On the basis of end-user, the segment is divided into providers, payers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America accounted for a majority of the chronic disease management market share in 2021 and is anticipated to remain dominant during the forecast period. The factors, such as favorable regulatory scenario, pressure on healthcare institutions to reduce costs, and rise in trends in healthcare IT, big data and cloud computing, well-established healthcare infrastructure, continuous reforms by governments, and an increase in diseased patient burden are driving the growth of the chronic disease management market in the regions.
For instance, the U.S. government implemented the Affordable Care Act (ACA) for the prevention of diseases and the adoption of healthcare IT. The ACA is expected to boost the growth of the chronic disease management market and create opportunities for population health management service providers to collect and maintain patients’ data.
The key players that operate in the chronic disease management market are WellSky, ZeOmega, Health Catalyst, Cedar Gate Technologies, Cognizant, Pegasystems Inc., Epic Systems Corporation, Hinduja Global Solutions Ltd. (Bengaluru), NXGN Management, LLC, MINES & Associates, Inc., Casenet, LLC, ExlServings Holdings, Inc., cliexa., ScienceSoft USA Corporation, Vivify Health, Inc., Allscripts Healthcare, LLC, Infosys Limited, Medecision, IBM, Altruista Health, TCS Healthcare Technologies, and Koninklijke Philips N.V. (Netherlands
Chronic disease management is an integrated care approach to managing the illness, which includes screenings, check-ups, monitoring and coordinating treatment, and patient education. It can improve the quality of life, while reducing healthcare costs. Chronic disease management programs are designed to improve the health of individuals with chronic conditions and reduce associated costs from avoidable complications by identifying and treating chronic conditions more quickly and more effectively; thus slowing the progression of those diseases.
The key factors that drive the growth of the market are an increase in awareness regarding the healthcare management service and a rise in the prevalence of chronic diseases such as cancer, heart disease, diabetes, high blood pressure, and others. According to a report published by the World Health Organization, in 2021, non-communicable diseases (NCDs) killed around 41 million people each year, which was 71% of all deaths globally. Moreover, improved services by the service provider have increased the demand for chronic disease management services in the market. The growth in the medical tourism sector and the rise in healthcare IT solutions drive the growth of the chronic disease management market. However, a lack of skilled professionals and high cost of treatment, and high investment in the management system/tools hinder the growth of the market.
The chronic disease management market is segmented on the basis of type, disease type, end user, and region. By type, the market is bifurcated into solutions and services. The solution segment is further classified on the basis of an on-premise solution and a cloud-based solution. On the basis of service, the segment is segmented into educational service, implementation service, and consulting service. On the basis of disease type, the segment is divided into cardiovascular disease, diabetes, cancer, asthma, a chronic obstructive pulmonary disorder, and others. On the basis of end-user, the segment is divided into providers, payers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America accounted for a majority of the chronic disease management market share in 2021 and is anticipated to remain dominant during the forecast period. The factors, such as favorable regulatory scenario, pressure on healthcare institutions to reduce costs, and rise in trends in healthcare IT, big data and cloud computing, well-established healthcare infrastructure, continuous reforms by governments, and an increase in diseased patient burden are driving the growth of the chronic disease management market in the regions.
For instance, the U.S. government implemented the Affordable Care Act (ACA) for the prevention of diseases and the adoption of healthcare IT. The ACA is expected to boost the growth of the chronic disease management market and create opportunities for population health management service providers to collect and maintain patients’ data.
The key players that operate in the chronic disease management market are WellSky, ZeOmega, Health Catalyst, Cedar Gate Technologies, Cognizant, Pegasystems Inc., Epic Systems Corporation, Hinduja Global Solutions Ltd. (Bengaluru), NXGN Management, LLC, MINES & Associates, Inc., Casenet, LLC, ExlServings Holdings, Inc., cliexa., ScienceSoft USA Corporation, Vivify Health, Inc., Allscripts Healthcare, LLC, Infosys Limited, Medecision, IBM, Altruista Health, TCS Healthcare Technologies, and Koninklijke Philips N.V. (Netherlands
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the chronic disease management market analysis from 2021 to 2031 to identify the prevailing chronic disease management market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the chronic disease management market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global chronic disease management market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Disease Type
- Cardiovascular diseases
- Diabetes
- Cancer
- Asthma
- Chronic obstructive pulmonary disorders
- Others
By Type
- Solutions
- Services
By End User
- Healthcare Providers
- Healthcare Payers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Italy
- Spain
- Rest of Europe
- Germany
- France
- U.K.
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Koninklijke Philips N.V
- Cognizant TriZetto Software Group Inc
- Cedar Gate Technologies
- Casenet, LLC
- cliexa, Inc
- Altruista Health
- Infosys Ltd
- Pegasystems Inc
- Epic Systems Corporation
- Hinduja Global Solutions Ltd
- NXGN Management, LLC
- ExlServings Holdings, Inc
- Vivify Health, Inc
- Allscripts Healthcare, LLC
- Medecision
- ZeOmega
- Health Catalyst
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE
CHAPTER 5: CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE
CHAPTER 6: CHRONIC DISEASE MANAGEMENT MARKET, BY END USER
CHAPTER 7: CHRONIC DISEASE MANAGEMENT MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, titled, “Chronic Disease Management Market," the Chronic Disease Management Market size was valued at $4.90 billion in 2021, and is estimated to reach $14.88 billion by 2031, growing at a CAGR of 11.8% from 2022 to 2031.Chronic diseases are long-term progressive ailments that are among the most expensive and common healthcare challenges in the world. Chronic disease management is a sort of digital healthcare service that assists healthcare providers in providing educational information to their patients and the implementation of patient- and illness-specific treatment alternatives and regimens. These services are specifically developed to help people manage chronic conditions and lessen their severity.
The Chronic Disease Management Market trends are an increase in awareness regarding healthcare management services and a rise in the prevalence of chronic diseases such as asthma, COPD, cancer, diabetes, stroke or musculoskeletal diseases across the globe. Moreover, improved services by service providers have increased the demand for chronic disease management services in the market. The growth in the medical tourism sector and the rise in healthcare IT solutions drive the Chronic Disease Management Market growth. However, a lack of skilled professional and high cost of treatment, and high investment in the management system/tools hinders the growth of the market.
COVID-19 Impact
Coronavirus (COVID-19) was discovered in late December 2019, in the Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted from humans to humans. Furthermore, the virus has high potential of lethality in the geriatric population. On March 11, 2020, the World Health Organization assessed that COVID-19 can be characterized as a pandemic.The overall impact of COVID-19 remains positive on the chronic disease management market. As the increase in the prevalence of COVID-19 has driven the demand for accurate diagnosis and treatment devices in several countries. In this regard, chronic disease management solutions have proven to be very helpful, as they allow healthcare providers to seamlessly integrate solutions such as EHR, patient management, and care management to healthcare payer solutions such as claim management and payment management solutions. Moreover, the rapid spread of this disease worldwide has resulted in lockdowns and restrictions, thereby increasing the demand for electronic data transfer and claim management. This is expected to increase the adoption of chronic disease management in the coming years as well.
On the basis of type, the chronic disease management market has been segmented into solutions and services. In 2021, the solution segment accounted for the largest share of the market. The dominance of this segment can be attributed to the increased adoption of software solutions by payers and providers to reduce readmissions, increase cost-effectiveness, improve operational efficiency, enhance patient engagement, and aid data integration and analysis.
On the basis of application, the diabetes segment exhibited the highest growth in 2021 and is anticipated to lead during the forecast period, owing to an increase in the prevalence of type 1 and type 2 diabetes across the world.
Depending on the end user the chronic disease management market is segmented into healthcare providers, healthcare payers, and others. In 2021, the healthcare providers segment accounted for the largest share of 48.0%. The large share of this segment was attributed to the implementation of the Affordable Care Act and Hospital Readmissions Reduction Program (aimed at lowering healthcare costs by using novel population health management solutions) in the U.S., as well as high demand for these solutions among healthcare providers across regions.
The Chronic Disease Management Industry is segmented on the basis of type, disease type, end user, and region. By type, the market is segmented into solutions and services. The solution segment is further classified on the basis of an on-premise solution and cloud-based solutions. On the basis of service, the segment is categorized into educational service, implementation service, and consulting service. On the basis of disease type, the segment is divided into cardiovascular disease, diabetes, cancer, asthma, a chronic obstructive pulmonary disorder, and others. On the basis of end-user, the segment is divided into providers, payers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America accounted for a majority of the chronic disease management market share in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to rising in the number of chronic disease cases, the presence of key players, and advancements in healthcare in the region. For instance, six in ten Americans live with at least one chronic disease, like heart disease and stroke, cancer, or diabetes which are leading causes of death and disability and they are also a leading driver of the healthcare costs in this region.
Asia-Pacific is anticipated to witness lucrative growth, owing to an increase in medical tourism, implementation of new ICT guidelines in Japan, investments, and reforms to modernize China’s healthcare infrastructure, rapid growth in the healthcare industry in India, and the implementation of IT programs in Australia and New Zealand. In addition, government initiatives for the adoption of HCIT, the growth in geriatric population, rise in prevalence of chronic diseases, increase in healthcare expenditure, and rise in purchasing power of consumers are also expected to support the market growth in this region.
The key players that operate in the chronic disease management market are ZeOmega, Health Catalyst, Cedar Gate Technologies, Cognizant, Pegasystems Inc., Epic Systems Corporation, Hinduja Global Solutions Ltd. (Bengaluru), NXGN Management, LLC, Casenet, LLC, ExlServings Holdings, Inc., cliexa, Inc., Vivify Health, Inc., Allscripts Healthcare, LLC, Infosys Limited, Medecision, Altruista Health, Koninklijke Philips N.V. (Netherlands)
Key Findings of the Study
- By Type, the solution segment was the highest contributor to the market in 2021.
- By Disease type, the diabetes segment was the highest contributor in 2021.
- By End user, the healthcare-providers dominated the market in 2021 and is expected to continue this trend during the forecast period.
- By Region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Koninklijke Philips N.V
- Cognizant Trizetto Software Group Inc,
- Cedar Gate Technologies
- Casenet, LLC
- Cliexa, Inc
- Altruista Health
- Infosys Ltd
- Pegasystems Inc
- Epic Systems Corporation
- Hinduja Global Solutions Ltd
- Nxgn Management, LLC
- Exlservings Holdings, Inc
- Vivify Health, Inc
- Allscripts Healthcare, LLC
- Medecision
- Zeomega
- Health Catalyst
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 281 |
| Published | July 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 4896.69 million |
| Forecasted Market Value ( USD | $ 14875.48 million |
| Compound Annual Growth Rate | 11.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
